Treace Medical Concepts (TMCI) Free Cash Flow Growth (1y) (2021 - 2026)
Treace Medical Concepts (TMCI) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | -14.34% |
| 10 | Treace Medical Concepts | 291.42 Mn | 245.80 Mn | 35.61 Mn | 11.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.74% |
| Mar 31, 2026 | 960.61% |
| Dec 31, 2025 | -402.72% |
| Sep 30, 2025 | 25.70% |
| Jun 30, 2025 | 100.92% |
| Mar 31, 2025 | 109.07% |
| Dec 31, 2024 | 61.33% |
| Sep 30, 2024 | -219.51% |
| Jun 30, 2024 | -10.59% |
| Mar 31, 2024 | 61.46% |
| Dec 31, 2023 | 46.29% |
| Sep 30, 2023 | -447.34% |
| Jun 30, 2023 | 20.10% |
| Mar 31, 2023 | -114.82% |
| Dec 31, 2022 | -442.16% |
| Sep 30, 2022 | 91.72% |
| Jun 30, 2022 | -257.35% |
| Mar 31, 2022 | -1,258.57% |
| Dec 31, 2021 | -259.39% |
| Sep 30, 2021 | -97.14% |